Ex-PRICE

🚀 Exciting update! We’ve just expanded the Ex-PRICE application with new reimbursement data for Sweden, France, Greece, and Slovenia! This enhancement empowers users with even more comprehensive insights across these key markets, supporting data-driven decisions and fostering transparency. 🌍📊 Thrilled to continue strengthening Ex-PRICE’s reach and impact—bringing more value to our partners across Europe. #DataInnovation #HealthcareReimbursement #ExPRICE #Europe

Learning from COVID-19: Long-term solutions 💡 The pandemic highlighted the need for better planning and flexibility. Companies that managed to react to it quickly did so thanks to preparedness and good business continuity plans. 📝 So, what can we do to better prepare for future challenges? Read our article where we discuss strategies and lessons from the pandemic to prepare for the future ➡ https://lnkd.in/dvQ-5qWy

Exciting Update from Ex-PRICE! 📢 Our reimbursement data keeps expanding! 📊 We're thrilled to announce the addition of new reimbursement data sources for Bulgaria, Cyprus, and Luxembourg. This expansion further enhances our ability to provide comprehensive and up-to-date pricing insights across multiple regions. Stay tuned for more updates as we continue to grow our data coverage and help you make better-informed decisions! #DataExpansion #HealthcareData #Reimbursement #PharmaPricing #ExPRICE

The economic impact of pandemic-related drug shortages 📉 It is obvious that pandemic-related shortages had a profound impact on patient treatment. ⚕️However, they also had broader economic implications.  To find out more about the economic and health impacts of these shortages, read our article ➡ https://lnkd.in/dvQ-5qWy

The hidden cost of COVID-19 😷 The COVID-19 pandemic exposed significant vulnerabilities in global pharmaceutical supply chains. From COVID-related medications to drugs for chronic disease management, drug shortages have affected patients all over the world. 💊 What was the impact of these shortages, and what lessons have we learned from them? Read our article to learn more ➡ https://lnkd.in/dvQ-5qWy

We are thrilled to announce that Ex-PRICE has expanded its global reach! 🎉 You can access comprehensive drug price data from Malaysia and Japan directly within the app. This update empowers you with more information to make well-informed decisions, ensuring you always get the best prices and options available. 🌐💊 Thank you for being a part of the Ex-PRICE community. Stay tuned for more updates as we continue to grow and improve our services. #Medication #PharmaceuticalData

Adapting to market dynamics 📊 Market dynamics play a vital role in shaping supply chain decisions, as they can worsen existing challenges. These dynamics include:  -changes in prescribing patterns and patient behavior,  -fluctuating raw material prices,  -changes in drug reimbursement policies,  -market competition from generics and new therapeutic alternatives,  -natural disasters and public health emergencies.    There isn’t much that can be done to avoid these issues, but staying agile and having a good contingency plan can help companies respond quicker when they arise. To learn more about this topic, read our blog ➡ https://lnkd.in/evB_67-i  

The impact of distribution problems on drug shortages 🚚    After addressing various manufacturing issues, distribution issues such as:  -transportation delays caused by accidents or strikes,  -inadequate storage conditions that affect drug stability,  -miscommunication due to the complexity of supply chains,  -regulatory issues in import/export processes,  can also result in drug shortages.     To overcome these hurdles, it is crucial to establish proper planning and inventory management procedures, which help create more resilient supply chains. 🔗 To find out more about the supply chain issues that can result in drug shortages, read our article ➡ https://lnkd.in/evB_67-i     #Pharmaceuticals #Logistics #PharmaDistribution #DrugShortages  

Addressing manufacturing challenges 🔍    In our last blog post, we talked about how drug shortages affect patient care and well-being. In our most recent blog, we explore the causes of these shortages, including various issues within the manufacturing process. 🏭    Key factors include:  -Technical challenges  -Resource constraints  -Equipment failures and breakdowns  -Regulatory issues and approval delays  -Drug contamination    -Inadequate quality assurance    Addressing these issues and ensuring a steady supply of medication requires careful oversight and robust quality assurance processes. Read our blog to learn more about this topic ➡ https://lnkd.in/evB_67-i     #Pharmaceuticals #DrugShortages #QualityControl #HealthcareInnovation   

THE HUMAN SIDE OF DRUG SHORTAGES 👥 Behind every statistic lies a human story. This is also the case when talking about drug shortages. Our newest blog takes a closer look at the human side of these shortages, focusing on patient experiences and the impact drug shortages have on their wellbeing.  By understanding their personal challenges when faced with drug shortages, we can come up with better solutions for these issues and advocate for better support systems. Read our article to learn more about this topic ➡️ https://lnkd.in/eCWTxjsc